Stenotrophomonas maltophilia is an opportunistic pathogen of significant concern to
susceptible patient populations. This pathogen can cause nosocomial and community …

Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …

While most bacteria are unicellular microbes they communicate with each other and with
their environments to adapt their behaviors. Quorum sensing (QS) is one of the best-studied …

In patients with cystic fibrosis (CF), the lung is a remarkable ecological niche in which the
microbiome is subjected to important selective pressures. An inexorable colonization by …

The isolation and characterization of bacteriophages for the treatment of infections caused
by the multidrug resistant pathogen Stenotrophomonas maltophilia is imperative as …

Fluorescently labeled bacterial cells have become indispensable for many aspects of
microbiological research, including studies on biofilm formation as an important virulence …

The Gram-negative pathogen Stenotrophomonas maltophilia causes a wide range of human
infections. It causes particularly serious lung infections in individuals with cystic fibrosis …

Background: Stenotrophomonas maltophilia (S. maltophilia) is an emerging opportunistic
Gram-negative rod causing nosocomial infections predominantly in immunocompromised …

Simple Summary Fluoroquinolones, mainly levofloxacin, are considered an alternative
treatment option of Stenotrophomonas maltophilia infections to trimethoprim …

Stenotrophomonas maltophilia is an opportunistic pathogen and frequent cause of serious
nosocomial infections. Patient populations at greatest risk for these infections include the …